Medicure (MCUJF) Interest Coverage Ratio (2009 - 2023)
Medicure's (MCUJF) quarterly Interest Coverage Ratio came in at 1045.6 in Q1 2023, up 738.95% year-on-year from 124.63 in Q1 2022, and up 12233.42% quarter-over-quarter from 8.48 in Q3 2022.
Medicure (MCUJF) Interest Coverage Ratio (2009 - 2023) Analysis & Trends
Medicure's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1045.6 for Q1 2023.
- On a quarterly basis, Interest Coverage Ratio rose 738.95% year-over-year to 1045.6 in Q1 2023; TTM through Mar 2026 was 2918582743421789.0, a 154.8% decrease from a year earlier, with the FY2017 full-year figure at 13.73, up 420.68% from the prior year.
- Interest Coverage Ratio improved to 1045.6 in Q1 2023 per MCUJF's latest filing, from 8.48 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1045.6 in Q1 2023 and bottomed at 13.57 in Q1 2020.
- The 4-year median for Interest Coverage Ratio is 3.47 (2022), against an average of 145.31.
- Across the five-year window, Interest Coverage Ratio soared 79.82% in 2022 and jumped 738.95% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 13.57 in 2020, then surged by 35.8% to 8.71 in 2021, then soared by 197.31% to 8.48 in 2022, then jumped by 12233.42% to 1045.6 in 2023.
- Per Business Quant, the three latest MCUJF Interest Coverage Ratio figures stand at 1045.6 (Q1 2023), 8.48 (Q3 2022), and 1.54 (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1,045.60 |
| Sep 30, 2022 | 8.48 |
| Jun 30, 2022 | -1.54 |
| Mar 31, 2022 | 124.63 |
| Sep 30, 2021 | -8.71 |
| Jun 30, 2021 | -7.65 |
| Mar 31, 2021 | 15.23 |
| Mar 31, 2020 | -13.57 |
| Mar 31, 2018 | 17.83 |
| Sep 30, 2017 | -1.11 |
| Jun 30, 2017 | -1.17 |
| Mar 31, 2017 | 5.23 |
| Dec 31, 2016 | 0.82 |
| Sep 30, 2016 | -67.27 |
| Jun 30, 2016 | -12.46 |
| Mar 31, 2016 | -21.15 |
| Dec 31, 2015 | 1.08 |
| Sep 30, 2015 | 2.14 |
| Jun 30, 2015 | -7.33 |
| Mar 31, 2015 | -5.30 |